bioRxiv Science⌕ Search

Biology subjects

Matsumura, Y.

Publications and source records attributed to Matsumura, Y..

20 records · Page 2Linked to original sources

Estimation of the Hemoglobin Glycation Rate Constant

AimIn a previous study, a method of obtaining mean erythrocyte age (MRBC) from HbA1c and average plasma glucose (AG) was proposed. However, the true value of the hemoglobin glycation constant (kg dL/mg/day), required for this model has yet to be well characterized. Another study also proposed a method of deriving MRBC from erythrocyte creatine (EC). Utilizing these formulae, this study aimed to determine a more accurate estimate of kg.\n\nMethods107 subjects including 31 patients with hemolytic anemia and 76 subjects without anemia were included in this study. EC and HbA1c data were analyzed, and MRBC using HbA1c, AG and the newly-derived constant, kg were compared to MRBC using traditional 51Cr in three patients whose data were taken from previous case studies.\n\nResultA value of 7.0 x 10-6 dL/mg/day was determined for kg. MRBC using HbA1c, AG and kg were found to no be significantly different (paired t-test, p = 0.45) to MRBC using traditional 51Cr.\n\nConclusionskg enables the estimation of MRBC from HbA1c and AG.

physiology↗

Significant antitumour effect of an antibody against TMEM180, a new cancer-specific molecule

The present state of therapy for colorectal cancer (CRC) is far from satisfactory, highlighting the need for new targets for this disease. We identified a new colorectal cancer (CRC)-specific molecule, TMEM180, a predicted eleven-pass transmembrane protein that apparently functions as a cation symporter. Our anti-TMEM180 monoclonal antibody (mAb) eradicated SW480 CRC xenografts in mice. The TMEM180 promoter region contains ten hypoxia-responsive element consensus sequences; accordingly SW480 cells upregulated TMEM180 under low-oxygen conditions. TMEM180 expression in SW480 cells was positively correlated with anchorage-independent colony formation and tumourigenesis. TMEM180-positive SW480 cells resided at the tumour-stroma interface manifested by SMA-positive fibroblasts, also known as the tumour niche. Some clusters of TMEM180-positive cells adjacent to the niche were integrin 6-positive. These data indicate that TMEM180 represents a possible cancer stem cell marker and that a mAb against this protein could be used as antibody-based therapeutic against CRC.

cancer biology↗